Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris
The general recommendations developed in this guideline are based on the Living Cochrane review (https://pubmed.ncbi.nlm.nih.gov/35603936/). With new evidence and new results becoming available, the guideline development group will consider these and decide if and when an update is necessary. This will also be the case for the recommendations for specific clinical and comorbid situations.
Download entire guideline document in the 2021 version:
Please note: The entire guideline document was last updated in 2021 and does not contain the latest information on the individual chapters. Below you can find the individual chapters that have been successively updated in the meantime. They will be incorporated into the entire guideline document when the updating process is completed.